Her main research concerns Mycobacterium tuberculosis, Tuberculosis, Adjuvant, Immunology and ESAT-6. Her Mycobacterium tuberculosis study combines topics in areas such as Proteome and Molecular biology. Ida Rosenkrands combines subjects such as Gene, Sequence analysis and Microbiology with her study of Tuberculosis.
As a member of one scientific family, Ida Rosenkrands mostly works in the field of Adjuvant, focusing on Immune system and, on occasion, Secretion. As a part of the same scientific study, Ida Rosenkrands usually deals with the Immunology, concentrating on Virology and frequently concerns with Antigen. Her work in ESAT-6 tackles topics such as Mycobacterium bovis which are related to areas like Immunodominance and Tuberculosis vaccines.
Mycobacterium tuberculosis, Tuberculosis, Immunology, Antigen and Virology are her primary areas of study. Her research on Mycobacterium tuberculosis focuses in particular on ESAT-6. Her study looks at the relationship between Tuberculosis and topics such as Disease, which overlap with Prospective cohort study.
Her Antigen study also includes fields such as
Her primary areas of study are Immunology, Antigen, Tuberculosis, Immune system and Mycobacterium tuberculosis. Her work on Antibody and Priming as part of general Immunology study is frequently connected to C-C chemokine receptor type 6, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. Her studies in Antigen integrate themes in fields like T cell, T cell differentiation, Microbiology and Vaccination.
Her Tuberculosis study combines topics from a wide range of disciplines, such as Internal medicine and Disease. Her Immune system research integrates issues from Chlamydia sp, Biochemistry, Nucleic acid and Virology. Ida Rosenkrands works mostly in the field of Mycobacterium tuberculosis, limiting it down to concerns involving Protein subunit and, occasionally, Bacillus Calmette-Guerin vaccination and Mycobacterium.
Her primary areas of study are Immunology, Tuberculosis, Disease, Antibody and Internal medicine. In general Immunology study, her work on Antigen and Bacterial vaccine often relates to the realm of Germinal center and C-C chemokine receptor type 6, thereby connecting several areas of interest. The Antigen study combines topics in areas such as Serology, Outpatient clinic and Confidence interval.
Active tb and Pulmonary tuberculosis are the core of her Tuberculosis study. Ida Rosenkrands focuses mostly in the field of Antibody, narrowing it down to topics relating to Chlamydia and, in certain cases, Virology. Her biological study spans a wide range of topics, including Epitope, Cytokine, Ferritin and Mycobacterium tuberculosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A Mycobacterium tuberculosis operon encoding ESAT-6 and a novel low-molecular-mass culture filtrate protein (CFP-10).
Fransois-Xavier Berthet;Peter Birk Rasmussen;Ida Rosenkrands;Peter Andersen.
Microbiology (1998)
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
Vadim Makarov;Giulia Manina;Katarina Mikusova;Ute Möllmann.
Science (2009)
ESAT-6 Subunit Vaccination against Mycobacterium tuberculosis
Lise Brandt;Martin Elhay;Ida Rosenkrands;Erik B. Lindblad.
Infection and Immunity (2000)
Human T Cell Responses to the ESAT-6 Antigen from Mycobacterium tuberculosis
Pernille Ravn;Abebech Demissie;Tewodros Eguale;Hailu Wondwosson.
The Journal of Infectious Diseases (1999)
Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells
Thomas Lindenstrøm;Else Marie Agger;Karen S. Korsholm;Patricia A. Darrah.
Journal of Immunology (2009)
Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens.
Rikke Louise Vinther Skjøt;Thomas Oettinger;Ida Rosenkrands;Pernille Ravn.
Infection and Immunity (2000)
Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate) - A novel adjuvant inducing both strong CMI and antibody responses
Jesper Davidsen;Ida Rosenkrands;Dennis Christensen;Anil Vangala.
Biochimica et Biophysica Acta (2005)
ESAT-6 proteins: protective antigens and virulence factors?
Priscille Brodin;Ida Rosenkrands;Peter Andersen;Stewart T. Cole.
Trends in Microbiology (2004)
Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements
Else Marie Agger;Ida Rosenkrands;Jon Hansen;Karima Brahimi.
PLOS ONE (2008)
Cationic liposomes as vaccine adjuvants
Dennis Christensen;Karen S Korsholm;Ida Rosenkrands;Thomas Lindenstrøm.
Expert Review of Vaccines (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Technical University of Denmark
Novo Nordisk (Denmark)
Institut Pasteur
Leiden University Medical Center
Max Planck Institute for Infection Biology
Institut Pasteur
Stellenbosch University
GlaxoSmithKline (United Kingdom)
London School of Hygiene & Tropical Medicine
Institut Pasteur
University of Edinburgh
University of Melbourne
Scuola Normale Superiore di Pisa
Swiss Federal Institute for Forest, Snow and Landscape Research
Topigs Norsvin (Netherlands)
University of Copenhagen
Oregon National Primate Research Center
University of Pittsburgh
University of Tennessee Health Science Center
University of Copenhagen
University of Paris-Saclay
Oregon State University
University of Washington
Indiana University
University of Virginia
National Institute for Astrophysics